News vTv's azeliragon is latest Alzheimer's drug failure US biotech vTv Therapeutics has become the latest to fail in Alzheimer’s disease, after a phase 3 trial of azeliragon missed its two main goals.
News Biotech vTv believes small molecule GLP-1 pill can take on b... US biotech vTv Therapeutics was showcasing mid-stage trial results from its oral small molecule GLP-1 pill at this year's American Diabetes Association conference, as it searches for partne
R&D Health Innovators – Jennifer Schranz In the rare and ultra-rare disease space, the paucity of both data and patients makes everything about research and development more complicated.
R&D Inside the new world of healthcare data These days, real-world data collection is in vogue and not hard to come by in healthcare research.